Zobrazeno 1 - 4
of 4
pro vyhledávání: '"A. J. Cunquero-Tomas"'
Autor:
Javier Martinez-Trufero, J. Lambea-Sorrosal, A. J. Cunquero-Tomas, Juan J. Grau, Antonio Lopez-Pousa, R. Hitt, N. Baste, M. Guix, X. León-Vintró, A. Berrocal-Jaime, C. García-Girón, Alberto Ocaña, Luciano Iglesias, Juan Jesús Cruz-Hernández, E. del Barco-Morillo
Publikováno v:
Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Our previous phase-3 study (TTCC 2503) failed to show overall survival advantage of 2 induction chemotherapy (IC) regimens followed by standard concurrent chemoradiotherapy (CRT) over CRT alone in patients with unresectable locally advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14994e2c3d82081612bc7239b868689a
https://doi.org/10.1007/s12094-020-02467-8
https://doi.org/10.1007/s12094-020-02467-8
Autor:
H.K. van Halteren, J. Bennouna, B. Brasiuniene, A. J. Cunquero Tomas, A. M. Garcia Trinidad, A. Indini, G. Liposits, B. Pellegrino, L. Popovic, A. Tan, R. Vidra, M. Strijbos
Publikováno v:
ESMO Open. 8:100773
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a4e3bedec3695efba0c8426e3de2058
https://doi.org/10.1016/j.esmoop.2022.100773
https://doi.org/10.1016/j.esmoop.2022.100773
Autor:
R, Hitt, L, Iglesias, A, López-Pousa, A, Berrocal-Jaime, J J, Grau, C, García-Girón, J, Martínez-Trufero, M, Guix, J, Lambea-Sorrosal, E, Del Barco-Morillo, X, León-Vintró, A J, Cunquero-Tomas, N, Baste, A, Ocaña, J J, Cruz-Hernández
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(4)
Our previous phase-3 study (TTCC 2503) failed to show overall survival advantage of 2 induction chemotherapy (IC) regimens followed by standard concurrent chemoradiotherapy (CRT) over CRT alone in patients with unresectable locally advanced head and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a51739048a34ea3e4aaaa8309971bbb4
https://pubmed.ncbi.nlm.nih.gov/32797376
https://pubmed.ncbi.nlm.nih.gov/32797376
Autor:
Alfonoso Berrocal, Blanca Ferrer-Guillen, Adrian Garcia-Medina, Amaya B Fernandez-Diaz, Alberto J Cunquero-Tomas
Publikováno v:
Melanoma research. 29(5)
The effectiveness and safety of nivolumab, an anti-programmed cell death protein 1 mAbmonoclonal antibody, in patients with renal replacement therapy is unclear, with limited evidence supporting its usefulness in this context. Therefore, we report a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a1059a9e29504049e44414aa5abf327
https://pubmed.ncbi.nlm.nih.gov/31464825
https://pubmed.ncbi.nlm.nih.gov/31464825